Poly Medicure Limited Share Price and Company Fundamentals
Last traded: Yesterday at 6:59 AM
Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal and tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. It offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. The company provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, ESR pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, universal caps, and ECG electrodes. The company was incorporated in 1995 and is based in New Delhi, India.
Key Metrics
PE ratio
61.02
PB ratio
10.72
Dividend yield
0.00%
Beta
-
Market cap
-
Enterprise value
-
Company profile
| Industry / Sector | Medical Instruments & Supplies / Healthcare |
|---|---|
| Website | https://www.polymedicure.com |
| Mailing address | 232B Okhla Industrial Estate 3rd Floor Phase III New Delhi 110020 India |
| Phone / Fax | 91 11 2632 1838 / 91 11 2632 1839 |
Dividends
Dividend yield
0.00%
Dividend amount
₹0.00
Payout ratio
11.15%
5Y Avg. yield
0.75%
Poly Medicure Limited paid ₹0.00 dividend and the ex-dividend date was 21 Sept 2023.The dividend payout ratio is 11.15%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.POLYMED dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
POLYMED's forward dividend amount is ₹3 and the forward dividend yield is 0.18%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of May 2024, following are the company executives and directors listed on Poly Medicure Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Himanshu Baid | CEO, MD & Director | 55 | 130.06M |
| Mr. Jugal Kishore Baid | Founder & Non Executive Director | 81 | 1.43M |
| Mr. Naresh Vijayvergiya | Chief Financial Officer | 56 | |
| Mr. Avinash Chandra | Company Secretary & Compliance Officer | ||
| Mr. Rishi Baid | Joint MD & Executive Director | 51 | 124.73M |
| Mr. Vishal Baid C.A. | President of Corporate Sales & Marketing | 49 | 17.15M |
| Mr. P. K. Rastogi | Assistant Vice President of Finance & Accounts | 52 | |
| Mr. Hemant Bhalla B.Sc. | Senior Vice President of Domestic Sales & Marketing | 64 | |
| Mr. Pankaj Kumar Gupta B.E. | President of R&D | 56 | |
| Mr. Manish Sardana | President of Sales & Marketing - India | 51 |
Profitability and management effectiveness
Profit margin
18.00%
Operating margin
31.85%
Return on assets
12.84%
Return on equity
19.05%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Poly Medicure Limited is and its enterprise value is .
Poly Medicure Limited (NSE:POLYMED) Frequently Asked Questions
1. What is Poly Medicure Limited's Stock Symbol?
Poly Medicure Limited trades on NSE under the ticker symbol "POLYMED".
2. What is Poly Medicure Limited's stock price today?
One share of POLYMED stock can currently be purchased for approximately ₹1655.
3. How can I contact Poly Medicure Limited?
Poly Medicure Limited's mailing address is 232B Okhla Industrial Estate 3rd Floor Phase III New Delhi 110020 India. The company can be reached via phone at 91 11 2632 1838.
4. What is Poly Medicure Limited's official website?
The official website of Poly Medicure Limited is https://www.polymedicure.com.